---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-053359"
form_type: "8-K"
ticker: "HOTH"
cik: "0001711786"
company_name: "Hoth Therapeutics, Inc."
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:08:16.848254+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Hoth Therapeutics board amends bylaws to clarify shareholder voting entitlement

## Summary
- Board approved Amendment No. 2 to Amended and Restated Bylaws on June 14, 2024.
- Amendment restates Article II, Section 2.7(b) regarding shareholders entitled to vote at meetings.
- Effective immediately; no impact on financials or operations disclosed.
- Exhibit 3.1 filed but not appended; details limited to procedural clarification.

## SEC filing metadata
- accession: 0001213900-24-053359
- form_type: 8-K
- ticker: HOTH
- cik: 0001711786
- company_name: Hoth Therapeutics, Inc.
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711786/000121390024053359/0001213900-24-053359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711786/000121390024053359/ea0207966-8k_hoththera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-053359
- JSON: https://secwatch.observer/filing/0001213900-24-053359.json
- Plain text: https://secwatch.observer/filing/0001213900-24-053359.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.